ADAGE CAPITAL PARTNERS GP, L.L.C. - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 59 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2024$24,933,291
+1.2%
609,765
+4.7%
0.05%0.0%
Q1 2024$24,627,939
-6.2%
582,634
-5.9%
0.05%
-14.8%
Q4 2023$26,254,334
-20.1%
619,206
-58.9%
0.05%
-28.0%
Q3 2023$32,875,456
+37.9%
1,505,976
+100.8%
0.08%
+44.2%
Q2 2023$23,842,500
+145.3%
750,000
+88.2%
0.05%
+136.4%
Q1 2023$9,719,903
-22.7%
398,5200.0%0.02%
-26.7%
Q4 2022$12,569,321
+11.6%
398,5200.0%0.03%
+7.1%
Q3 2022$11,262,000
+33.1%
398,520
+24.5%
0.03%
+47.4%
Q2 2022$8,461,000
-39.6%
320,000
-20.0%
0.02%
-29.6%
Q1 2022$14,004,000
+39.3%
400,000
+29.0%
0.03%
+50.0%
Q4 2021$10,050,000
+36.3%
310,000
+24.0%
0.02%
+20.0%
Q3 2021$7,375,000
-42.4%
250,000
-50.0%
0.02%
-40.0%
Q2 2021$12,810,000
+55.5%
500,000
-16.7%
0.02%
+47.1%
Q1 2021$8,238,000
-17.2%
600,0000.0%0.02%
-22.7%
Q4 2020$9,948,000600,0000.02%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2020
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 65,679,781$2,685,646,24557.02%
Twin Securities, Inc. 416,657$17,037,10513.40%
Sand Grove Capital Management LLP 919,023$37,578,85010.99%
Perceptive Advisors 10,794,876$441,402,48010.63%
P SCHOENFELD ASSET MANAGEMENT LP 796,440$32,566,4327.87%
ALPINE ASSOCIATES MANAGEMENT INC. 2,353,694$96,242,5474.60%
Avoro Capital Advisors LLC 7,539,547$308,292,0774.11%
Melqart Asset Management (UK) Ltd 1,099,229$44,947,4743.72%
Paradigm Biocapital Advisors LP 2,330,508$95,294,4723.65%
WATER ISLAND CAPITAL LLC 766,933$31,3603.33%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders